Withuspharmaceutical (Korea) Today
| 330350 Stock | KRW 6,740 40.00 0.60% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Withuspharmaceutical is trading at 6740.00 as of the 29th of November 2024, a 0.60 percent increase since the beginning of the trading day. The stock's open price was 6700.0. Withuspharmaceutical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Withuspharmaceutical CoLtd are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of August 2024 and ending today, the 29th of November 2024. Click here to learn more.
Withus Pharmaceutical Co., Ltd. produces and sells pharmaceutical products in South Korea. The company was founded in 2005 and is headquartered in Seoul, South Korea. Withus Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea. More on Withuspharmaceutical CoLtd
Moving together with Withuspharmaceutical Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Withuspharmaceutical Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Withuspharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Withuspharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Pharmaceuticals, Healthcare (View all Sectors) |
Withuspharmaceutical CoLtd (330350) is traded on KOSDAQ in Korea . The company currently falls under 'Mega-Cap' category with a current market capitalization of 122.03 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Withuspharmaceutical's market, we take the total number of its shares issued and multiply it by Withuspharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Withuspharmaceutical operates under Healthcare sector and is part of Pharmaceuticals industry.
Withuspharmaceutical CoLtd has accumulated about 13.83 B in cash with 8.02 B of positive cash flow from operations.
Check Withuspharmaceutical Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Withuspharmaceutical is W122.03 Billion. Withuspharmaceutical owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the company is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Withuspharmaceutical Ownership Details
Withuspharmaceutical Risk Profiles
Although Withuspharmaceutical's alpha and beta are two of the key measurements used to evaluate Withuspharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.46 | |||
| Standard Deviation | 2.05 | |||
| Variance | 4.22 | |||
| Risk Adjusted Performance | (0.11) |
Withuspharmaceutical Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Withuspharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Other Information on Investing in Withuspharmaceutical Stock
Withuspharmaceutical financial ratios help investors to determine whether Withuspharmaceutical Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Withuspharmaceutical with respect to the benefits of owning Withuspharmaceutical security.